News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92,378 Results
Type
Article (3070)
Company Profile (20)
Press Release (89288)
Section
Business (38735)
Career Advice (60)
Deals (5964)
Drug Delivery (12)
Drug Development (11571)
Employer Resources (7)
FDA (2096)
Job Trends (2392)
News (56143)
Policy (3426)
Tag
Academia (275)
Accelerated approval (2)
Adcomms (2)
Allergies (23)
Alliances (3563)
ALS (10)
Alzheimer's disease (204)
Antibody-drug conjugate (ADC) (32)
Approvals (2156)
Artificial intelligence (28)
Autoimmune disease (2)
Automation (1)
Bankruptcy (17)
Best Places to Work (2201)
Biosimilars (16)
Biotechnology (14)
Bladder cancer (29)
Brain cancer (4)
Breast cancer (95)
Cancer (645)
Cardiovascular disease (44)
Career advice (56)
Career pathing (4)
CAR-T (18)
CDC (3)
Cell therapy (50)
Cervical cancer (5)
Clinical research (10528)
Collaboration (104)
Compensation (136)
Complete response letters (4)
COVID-19 (227)
CRISPR (11)
C-suite (34)
Cystic fibrosis (21)
Data (755)
Depression (20)
Diabetes (48)
Diagnostics (877)
Digital health (7)
Diversity, equity & inclusion (1)
Drug discovery (20)
Drug pricing (9)
Drug shortages (3)
Duchenne muscular dystrophy (32)
Earnings (33665)
Editorial (9)
Employer branding (2)
Employer resources (7)
Events (11332)
Executive appointments (43)
FDA (2596)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (91)
Gene editing (20)
Generative AI (2)
Gene therapy (46)
GLP-1 (126)
Government (446)
Grass and pollen (1)
Guidances (255)
Healthcare (2842)
HIV (3)
Huntington's disease (3)
IgA nephropathy (12)
Immunology and inflammation (26)
Immuno-oncology (2)
Indications (13)
Infectious disease (257)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (8)
Intellectual property (15)
Interviews (6)
IPO (4261)
IRA (3)
Job creations (295)
Job search strategy (48)
Kidney cancer (5)
Labor market (17)
Layoffs (65)
Leadership (1)
Legal (574)
Liver cancer (12)
Lung cancer (110)
Lymphoma (81)
Management (2)
Manufacturing (38)
MASH (16)
Medical device (2146)
Medtech (2150)
Mergers & acquisitions (1812)
Metabolic disorders (115)
Multiple sclerosis (23)
NASH (3)
Neurodegenerative disease (15)
Neuropsychiatric disorders (7)
Neuroscience (321)
NextGen: Class of 2025 (795)
Non-profit (388)
Now hiring (5)
Obesity (51)
Opinion (6)
Ovarian cancer (25)
Pain (17)
Pancreatic cancer (16)
Parkinson's disease (35)
Partnered (1)
Patents (30)
Patient recruitment (21)
Peanut (10)
People (3078)
Pharmaceutical (6)
Pharmacy benefit managers (2)
Phase I (2503)
Phase II (4284)
Phase III (4456)
Pipeline (1143)
Policy (4)
Postmarket research (441)
Preclinical (710)
Press Release (1)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (49)
Rare diseases (68)
Real estate (382)
Recruiting (3)
Regulatory (2799)
Reports (14)
Research institute (206)
Resumes & cover letters (2)
Rett syndrome (2)
RNA editing (2)
RSV (14)
Schizophrenia (12)
Series A (11)
Series B (13)
Service/supplier (2)
Sickle cell disease (10)
Special edition (7)
Spinal muscular atrophy (48)
Sponsored (2)
Startups (260)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (3)
Vaccines (77)
Venture capital (9)
Weight loss (25)
Women's health (6)
Worklife (4)
Date
Last 7 days (64)
Last 30 days (291)
Last 365 days (5676)
2025 (4100)
2024 (6123)
2023 (6916)
2022 (8318)
2021 (8139)
2020 (8155)
2019 (6924)
2018 (5075)
2017 (4621)
2016 (3831)
2015 (4361)
2014 (3192)
2013 (2086)
2012 (2497)
2011 (2731)
2010 (2789)
Location
Africa (67)
Alabama (33)
Alaska (1)
Arizona (26)
Asia (5286)
Australia (905)
California (1445)
Canada (426)
China (94)
Colorado (65)
Connecticut (55)
Delaware (69)
Europe (14549)
Florida (230)
Georgia (50)
Idaho (8)
Illinois (93)
India (3)
Indiana (92)
Iowa (5)
Japan (66)
Kansas (12)
Kentucky (7)
Louisiana (6)
Maine (20)
Maryland (162)
Massachusetts (1166)
Michigan (34)
Minnesota (92)
Missouri (10)
Montana (3)
Nebraska (2)
Nevada (12)
New Hampshire (15)
New Jersey (468)
New York (404)
North Carolina (192)
North Dakota (1)
Northern California (733)
Ohio (32)
Oklahoma (1)
Oregon (1)
Pennsylvania (320)
South America (107)
South Carolina (3)
Southern California (567)
Tennessee (14)
Texas (210)
United States (5429)
Utah (34)
Virginia (14)
Washington D.C. (3)
Washington State (156)
Wisconsin (9)
92,378 Results for "32".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immuno-Oncology Drugs Market Forecast to Hit USD 32.32 Billion in 2025 Amid Rising Cancer Incidence
June 18, 2025
·
1 min read
Press Releases
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
August 26, 2025
·
7 min read
Press Releases
Conformal Medical Closes $32 Million Series D Extension to Advance its Next-Generation Left Atrial Appendage Occlusion Technology
August 13, 2025
·
3 min read
Press Releases
32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones
June 10, 2025
·
5 min read
Layoffs
Caribou Changes Course Again, Lays Off 32% of Workforce
The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The move follows a reconfiguration last year to move into immunology.
April 25, 2025
·
1 min read
·
Dan Samorodnitsky
Legal
Former Chinook Board Member Indicted for Insider Trading Related to $3.2B Novartis Buy
Rouzbeh Haghighat was serving on the board of Chinook Therapeutics at the time of the Novartis acquisition and, according to the DOJ’s allegations, used confidential information to conduct insider trading.
May 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod’s Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated Reduction in a Key Plasma Biomarker of Neurodegeneration
July 29, 2025
·
11 min read
Press Releases
Q32 Bio Joins Russell 3000® Index
Q32 Bio Inc. today announced that the company is joining the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell Indexes annual reconstitution, effective upon the U.S. market opening today, July 1, 2024.
July 1, 2024
·
6 min read
Business
Lilly Pays $3.2B to Buy Morphic and Deepen Immunology, Gastro Portfolio
Eli Lilly on Monday announced a $3.2 billion all-cash deal to purchase Morphic and its pipeline of oral integrin therapies in a move to expand the pharma’s presence in the autoimmune diseases space.
July 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Nuclear Medicine Market Size to Hit USD 32.40 Billion by 203
February 19, 2025
·
1 min read
1 of 9,238
Next
